Fenton Mary Kay
SEC CIK 1378589 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | CFO | 127.9K | — | $59.9K | 5 | 2025-02-19 | 2026-06-30 |
Most active insiders at CGEM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 10% | $11.93M | — |
| 2 | Michaelson Jennifer | CSO | — | $1.62M |
| 3 | Nichols Weston | 10% | $1.39M | — |
| 4 | AHMED NADIM | Pres, CEO, Dir | — | $518.0K |
| 5 | Jones Jeffrey Alan | Chief Medical Off | — | $178.9K |
| 6 | SUMER JACQUELYN L | CLO | — | $136.7K |
| 7 | Fenton Mary Kay | CFO | — | $59.9K |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 17:00 | 2026-06-30 | CGEM | Cullinan Therapeutics, Inc. | Fenton Mary Kay | CFO | A - Grant | $8.60 | +1,541 | 127.9K | +1% | +$13.3K | |
| 2026-02-23 | 2026-02-20 | CGEM | Cullinan Therapeutics, Inc. | Fenton Mary Kay | CFO | S - Sale | $13.62 | -4,398 | 126.4K | -3% | -$59.9K | |
| D | 2026-02-19 | 2026-02-18 | CGEM | Cullinan Therapeutics, Inc. | Fenton Mary Kay | CFO | A - Grant | $0.00 | +68.8K | 130.8K | +111% | $0 |
| 2026-01-05 | 2025-12-31 | CGEM | Cullinan Therapeutics, Inc. | Fenton Mary Kay | CFO | A - Grant | $6.49 | +27 | 62.0K | +0.0% | +$175.23 | |
| D | 2025-02-21 | 2025-02-19 | CGEM | Cullinan Therapeutics, Inc. | Fenton Mary Kay | CFO | A - Grant | $0.00 | +60.0K | 60.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations